Single products focus on coronary disease treatment!Can this company can IPO by relying on the drug to elute the balloon?
The structure of Yiyi Biological Products is relatively single, and 90 % of the in...
Evergrande's small and medium -sized supply business dilemma
Behind each of the trapped companiesThere must be more people who are in troubleAt...